Published in J Infect Dis on May 09, 2001
The causal relation between human papillomavirus and cervical cancer. J Clin Pathol (2002) 14.73
GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol (2002) 5.63
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin (2012) 5.58
Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States. J Natl Cancer Inst (2009) 3.77
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. J Low Genit Tract Dis (2012) 3.15
Model for assessing human papillomavirus vaccination strategies. Emerg Infect Dis (2007) 2.93
Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2. Obstet Gynecol (2009) 2.74
Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18. Clin Diagn Lab Immunol (2005) 2.72
Human papillomavirus genotype specificity of hybrid capture 2. J Clin Microbiol (2008) 2.51
Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J Clin Pathol (2004) 2.16
Anal human papillomavirus infection in women and its relationship with cervical infection. Cancer Epidemiol Biomarkers Prev (2005) 2.11
Analysis of the effect of DNA purification on detection of human papillomavirus in oral rinse samples by PCR. J Clin Microbiol (2005) 1.81
Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer. J Clin Microbiol (2006) 1.79
Prevalence of type-specific HPV infection by age and grade of cervical cytology: data from the ARTISTIC trial. Br J Cancer (2008) 1.77
Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome. Mol Cancer (2003) 1.73
Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study. Cancer Res (2008) 1.73
CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression. J Virol (2003) 1.72
Detection of precancerous cervical lesions is differential by human papillomavirus type. Cancer Res (2009) 1.67
Human papillomavirus type 18 DNA load and 2-year cumulative diagnoses of cervical intraepithelial neoplasia grades 2-3. J Natl Cancer Inst (2009) 1.65
Comparison of two PCR-based human papillomavirus genotyping methods. J Clin Microbiol (2008) 1.59
A population-based study of human papillomavirus genotype prevalence in the United States: baseline measures prior to mass human papillomavirus vaccination. Int J Cancer (2012) 1.47
Comparison of physician- and self-collected genital specimens for detection of human papillomavirus in men. J Clin Microbiol (2006) 1.46
Relationship between prevalent oral and cervical human papillomavirus infections in human immunodeficiency virus-positive and -negative women. J Clin Microbiol (2006) 1.46
Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination. Popul Health Metr (2007) 1.39
Results of the first World Health Organization international collaborative study of detection of human papillomavirus DNA. J Clin Microbiol (2006) 1.38
The distribution of sexually-transmitted Human Papillomaviruses in HIV positive and negative patients in Zambia, Africa. BMC Infect Dis (2007) 1.36
Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program. BMC Med (2011) 1.23
Pilot study of a commercialized human papillomavirus (HPV) genotyping assay: comparison of HPV risk group to cytology and histology. J Clin Microbiol (2006) 1.19
Relationship between cigarette smoking and human papilloma virus types 16 and 18 DNA load. Cancer Epidemiol Biomarkers Prev (2009) 1.18
Genital human papillomavirus genotypes in northwestern Tanzania. J Clin Microbiol (2003) 1.10
Facile, comprehensive, high-throughput genotyping of human genital papillomaviruses using spectrally addressable liquid bead microarrays. J Mol Diagn (2005) 1.07
Human papillomavirus infection and use of oral contraceptives. Br J Cancer (2003) 1.07
Human papillomavirus genotyping after denaturation of specimens for Hybrid Capture 2 testing: feasibility study for the HPV persistence and progression cohort. J Virol Methods (2007) 1.05
Nonisotopic detection of human papillomavirus DNA in clinical specimens using a consensus PCR and a generic probe mix in an enzyme-linked immunosorbent assay format. J Clin Microbiol (2001) 1.05
Human papillomavirus genotypes in cervical intraepithelial neoplasia grade 3. Cancer Epidemiol Biomarkers Prev (2010) 1.05
Clinical evaluation of the cartridge-based GeneXpert human papillomavirus assay in women referred for colposcopy. J Clin Microbiol (2014) 1.04
Evaluation of a new DNA test for detection of carcinogenic human papillomavirus. J Clin Microbiol (2011) 1.02
Detection of genomic amplification of the human telomerase gene TERC, a potential marker for triage of women with HPV-positive, abnormal Pap smears. Am J Pathol (2009) 1.02
Development and evaluation of a liquid bead microarray assay for genotyping genital human papillomaviruses. J Clin Microbiol (2009) 1.00
Frequency of extracolonic tumors in Brazilian families with Lynch syndrome: analysis of a hereditary colorectal cancer institutional registry. Fam Cancer (2010) 0.99
Impact of improved classification on the association of human papillomavirus with cervical precancer. Am J Epidemiol (2009) 0.95
Biomarkers of cervical dysplasia and carcinoma. J Oncol (2011) 0.94
Human papillomavirus types 16 and 18 DNA load in relation to coexistence of other types, particularly those in the same species. Cancer Epidemiol Biomarkers Prev (2009) 0.93
A study of Amplicor human papillomavirus DNA detection in the atypical squamous cells of undetermined significance-low-grade squamous intraepithelial lesion triage study. Cancer Epidemiol Biomarkers Prev (2009) 0.92
Comparison of measurements of human papillomavirus persistence for postcolposcopic surveillance for cervical precancerous lesions. Cancer Epidemiol Biomarkers Prev (2010) 0.91
Mapping common deleted regions on 5p15 in cervical carcinoma and their occurrence in precancerous lesions. Mol Cancer (2002) 0.89
The viral etiology of AIDS-associated malignancies. Adv Pharmacol (2008) 0.89
The influence of type-specific human papillomavirus infections on the detection of cervical precancer and cancer: A population-based study of opportunistic cervical screening in the United States. Int J Cancer (2014) 0.88
Detection of telomerase, its components, and human papillomavirus in cervical scrapings as a tool for triage in women with cervical dysplasia. J Clin Pathol (2003) 0.86
Risk of precancer determined by HPV genotype combinations in women with minor cytologic abnormalities. Cancer Epidemiol Biomarkers Prev (2013) 0.86
Baseline assessment of prevalence and geographical distribution of HPV types in Chile using self-collected vaginal samples. BMC Public Health (2008) 0.85
Human papillomavirus genotype-specific prevalence across the continuum of cervical neoplasia and cancer. Cancer Epidemiol Biomarkers Prev (2014) 0.85
Detection of HPV DNA in paraffin-embedded cervical samples: a comparison of four genotyping methods. BMC Infect Dis (2015) 0.84
Short-term natural history of high-risk human papillomavirus infection in mid-adult women sampled monthly. Int J Cancer (2015) 0.83
Reducing the health burden of HPV infection through vaccination. Infect Dis Obstet Gynecol (2006) 0.83
Predictors of human papillomavirus infection in women undergoing routine cervical cancer screening in Spain: the CLEOPATRE study. BMC Infect Dis (2012) 0.83
Influence of loop electrosurgical excision procedure on subsequent acquisition of new human papillomavirus infections. J Infect Dis (2009) 0.81
Human papillomavirus infection in Honduran women with normal cytology. Cancer Causes Control (2009) 0.79
The prevalence of human papillomavirus and its impact on cervical dysplasia in Northern Canada. Infect Agent Cancer (2013) 0.79
Prevalence and risk factors for High-Risk Human Papillomavirus (hrHPV) infection among HIV-infected and Uninfected Rwandan women: implications for hrHPV-based screening in Rwanda. Infect Agent Cancer (2014) 0.78
Human papillomavirus infections in primary care. Clin Med Res (2007) 0.78
Three-year risk of cervical precancer and cancer after the detection of low-risk human papillomavirus genotypes targeted by a commercial test. Obstet Gynecol (2014) 0.77
Performance of cytology and human papillomavirus testing in relation to the menstrual cycle. Br J Cancer (2006) 0.77
A prospective study of absolute risk and determinants of human papillomavirus incidence among young women in Costa Rica. BMC Infect Dis (2013) 0.75
p16 Immunostaining of Canine Squamous Cell Carcinomas Is Not Associated with Papillomaviral DNA. PLoS One (2016) 0.75
Improved amplification of genital human papillomaviruses. J Clin Microbiol (2000) 11.50
Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol (1998) 9.43
Neurogenesis in the adult is involved in the formation of trace memories. Nature (2001) 8.13
Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis (1994) 7.00
Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years. Lancet (2009) 5.68
Stimulation of bone formation in vitro and in rodents by statins. Science (1999) 5.55
Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis (1994) 4.89
Geographic variation in the treatment of localized breast cancer. N Engl J Med (1992) 4.39
A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16. J Natl Cancer Inst (1994) 3.95
Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections. EMBO J (1993) 3.85
Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991. Cancer (1997) 3.70
Mortality risk among hemodialysis patients receiving different vitamin D analogs. Kidney Int (2006) 3.63
"U" curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc. Kidney Int (1998) 3.53
Imaging the surface of Altair. Science (2007) 3.03
Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study. J Natl Cancer Inst (2001) 3.00
The effect of marital status on stage, treatment, and survival of cancer patients. JAMA (1987) 2.99
Dendrimer-encapsulated metal nanoparticles: synthesis, characterization, and applications to catalysis. Acc Chem Res (2001) 2.85
Choice of cancer therapy varies with age of patient. JAMA (1986) 2.58
Characterization of the structure and function of the fourth member of p38 group mitogen-activated protein kinases, p38delta. J Biol Chem (1997) 2.47
Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts. J Clin Microbiol (1995) 2.46
PRAK, a novel protein kinase regulated by the p38 MAP kinase. EMBO J (1998) 2.44
Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc Natl Acad Sci U S A (1994) 2.41
Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol (1997) 2.40
Travel distance to radiation therapy and receipt of radiotherapy following breast-conserving surgery. J Natl Cancer Inst (2000) 2.38
Selective inhibitors of the osteoblast proteasome stimulate bone formation in vivo and in vitro. J Clin Invest (2003) 2.30
Absence of cardiolipin in the crd1 null mutant results in decreased mitochondrial membrane potential and reduced mitochondrial function. J Biol Chem (2000) 2.26
Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies. J Clin Microbiol (1998) 2.21
Cloning and functional analysis of cDNAs with open reading frames for 300 previously undefined genes expressed in CD34+ hematopoietic stem/progenitor cells. Genome Res (2000) 2.21
Interferon-gamma-induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis. Mol Med (1995) 2.15
Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J Virol (1995) 2.13
THE ROLE OF THE BURROWING OWL AND THE STICKTIGHT FLEA IN THE SPREAD OF PLAGUE. Science (1941) 2.12
Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J Natl Cancer Inst (1997) 2.06
Breastfeeding reduces risk of respiratory illness in infants. Am J Epidemiol (1998) 2.05
Determinants of cancer therapy in elderly patients. Cancer (1993) 1.93
Prevalence of psychiatric disorders among persons convicted of driving while impaired. Arch Gen Psychiatry (2001) 1.93
The recovery of cognitive function after general anesthesia in elderly patients: a comparison of desflurane and sevoflurane. Anesth Analg (2001) 1.92
Risk factors for rapid-onset cervical cancer. Am J Obstet Gynecol (1999) 1.91
Involvement of the MKK6-p38gamma cascade in gamma-radiation-induced cell cycle arrest. Mol Cell Biol (2000) 1.88
Human papillomavirus type 16 variants and risk of cervical cancer. J Natl Cancer Inst (2001) 1.86
Sphingosine-induced apoptosis is dependent on lysosomal proteases. Biochem J (2001) 1.80
p62(dok), a negative regulator of Ras and mitogen-activated protein kinase (MAPK) activity, opposes leukemogenesis by p210(bcr-abl). J Exp Med (2001) 1.73
Multiple lineages of tumors express a common tumor antigen, P1A, but they are not cross-protected. J Immunol (1995) 1.68
Human papillomavirus: a highly prevalent sexually transmitted disease agent among female sex workers from Mexico City. Sex Transm Dis (2001) 1.68
Intratype variation in 12 human papillomavirus types: a worldwide perspective. J Virol (1996) 1.65
Epidemiology and partial nucleotide sequence of four novel genital human papillomaviruses. J Infect Dis (1994) 1.64
Sample preparation and PCR amplification from paraffin-embedded tissues. PCR Methods Appl (1994) 1.64
A pharmacodynamic study of sorafenib in patients with relapsed and refractory acute leukemias. Leukemia (2010) 1.61
Consistent associations of HLA class I and II and transporter gene products with progression of human immunodeficiency virus type 1 infection in homosexual men. J Infect Dis (1999) 1.60
Control of Typhus in Italy 1943-1944 by Use of DDT. Am J Public Health Nations Health (1946) 1.60
The amplitude and time course of the myoplasmic free [Ca2+] transient in fast-twitch fibers of mouse muscle. J Gen Physiol (1996) 1.58
Determinants of genital human papillomavirus infection among cytologically normal women attending the University of New Mexico student health center. Sex Transm Dis (1993) 1.57
Big mitogen-activated kinase regulates multiple members of the MEF2 protein family. J Biol Chem (2000) 1.57
Predicting extracapsular extension of prostate cancer in men treated with radical prostatectomy: results from the population based prostate cancer outcomes study. J Urol (1999) 1.56
Determinants of survival in older cancer patients. J Natl Cancer Inst (1996) 1.56
Population differences in SLE susceptibility genes: STAT4 and BLK, but not PXK, are associated with systemic lupus erythematosus in Hong Kong Chinese. Genes Immun (2009) 1.55
Targeted therapy of spinal cord glioma with a genetically modified Salmonella typhimurium. Cell Prolif (2009) 1.55
HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nat Genet (1994) 1.52
Proliferative activity of calcifying odontogenic cysts as evaluated by proliferating cell nuclear antigen labeling index. Pathol Int (1998) 1.51
Trends in Gleason score for prostate cancer diagnosed between 1983 and 1993. J Urol (2001) 1.49
Tie2-mediated loss of peroxisome proliferator-activated receptor-gamma in mice causes PDGF receptor-beta-dependent pulmonary arterial muscularization. Am J Physiol Lung Cell Mol Physiol (2009) 1.47
T cell determinant structure: cores and determinant envelopes in three mouse major histocompatibility complex haplotypes. J Exp Med (1991) 1.47
Distinct costimulatory molecules are required for the induction of effector and memory cytotoxic T lymphocytes. J Exp Med (1997) 1.47
The effects of differing resistance training modes on the preservation of bone mineral density in postmenopausal women: a meta-analysis. Osteoporos Int (2015) 1.47
Occupational and environmental risk factors for idiopathic pulmonary fibrosis: a multicenter case-control study. Collaborating Centers. Am J Epidemiol (2000) 1.46
Searches for Lepton flavor violation in the decays tau{+/-}-->e{+/-}gamma and tau{+/-}-->mu{+/-}gamma. Phys Rev Lett (2010) 1.44
Biologic characteristics of interval and screen-detected breast cancers. J Natl Cancer Inst (2000) 1.44
Genetic evaluation of suspected cases of transient HIV-1 infection of infants. Science (1998) 1.43
Defect in SHAP-hyaluronan complex causes severe female infertility. A study by inactivation of the bikunin gene in mice. J Biol Chem (2001) 1.42
Clinical chemistry reference intervals for healthy elderly subjects. Am J Clin Nutr (1989) 1.41
Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18. Int J Cancer (2011) 1.41
Detection of clonal B cell populations in paraffin-embedded tissues by polymerase chain reaction. Am J Pathol (1993) 1.38
Activated caspase-3 expression in Alzheimer's and aged control brain: correlation with Alzheimer pathology. Brain Res (2001) 1.36
Delay in seeking care for cancer symptoms: a population-based study of elderly New Mexicans. J Natl Cancer Inst (1988) 1.36
Nutritional status in a healthy elderly population: vitamin D. Am J Clin Nutr (1982) 1.35
Gene-targeted B-deficient mice reveal a critical role for B cells in the CD4 T cell response. Int Immunol (1995) 1.35
Idiopathic pulmonary fibrosis: survival in population based and hospital based cohorts. Thorax (1998) 1.29
Adsorption, purification, and growth characteristics of hepatitis A virus strain HAS-15 propagated in fetal rhesus monkey kidney cells. J Clin Microbiol (1986) 1.29
Cervical papillomavirus infection and cervical dysplasia in Hispanic, Native American, and non-Hispanic white women in New Mexico. Am J Public Health (1991) 1.29
Physician acceptance of the hepatitis B vaccine at a university medical center. Am J Public Health (1988) 1.28
Identification of amino acids in the factor XI apple 3 domain required for activation of factor IX. J Biol Chem (1999) 1.28
Thyroid failure in the elderly. Microsomal antibodies as discriminant for therapy. JAMA (1987) 1.28
Effect of variations in operational definitions on performance estimates for screening mammography. Acad Radiol (2000) 1.27
Comparison of dot filter hybridization, Southern transfer hybridization, and polymerase chain reaction amplification for diagnosis of anal human papillomavirus infection. J Clin Microbiol (1993) 1.26
Nitrogen dioxide and respiratory illnesses in infants. Am Rev Respir Dis (1993) 1.25
Alcohol intake in the healthy elderly. Changes with age in a cross-sectional and longitudinal study. J Am Geriatr Soc (1990) 1.24
Nutritional status in a healthy elderly population: vitamin C. Am J Clin Nutr (1982) 1.21
Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer. Br J Cancer (2010) 1.21
The search for structure-specific nucleic acid-interactive drugs: effects of compound structure on RNA versus DNA interaction strength. Biochemistry (1993) 1.21
Sexually transmitted diseases and other risk factors for cervical dysplasia among southwestern Hispanic and non-Hispanic white women. JAMA (1994) 1.21
Synthesis of dicationic diaryltriazines nucleic acid binding agents. Eur J Med Chem (1994) 1.20
Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas. Cancer Epidemiol Biomarkers Prev (1999) 1.19
Determinants of receiving breast-conserving surgery. The Surveillance, Epidemiology, and End Results Program, 1983-1986. Cancer (1994) 1.18
Patterns of mammography use among Hispanic, American Indian, and non-Hispanic White women in New Mexico, 1994-1997. Am J Epidemiol (2000) 1.18
Increasing incidence of colon and rectal cancer among Hispanics and American Indians in New Mexico (United States), 1969-94. Cancer Causes Control (1998) 1.17
Targeting microRNA-30a-mediated autophagy enhances imatinib activity against human chronic myeloid leukemia cells. Leukemia (2012) 1.17